Hematology / Oncology / Cancer Center / Breast Clinic

Research output

Research output per year 1978 2007 2008 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 1708 Article
• 271 Review article
• 130 Letter
• 48 Comment/debate
• 71 More
  • 32 Chapter
  • 21 Editorial
  • 13 Short survey
  • 2 Conference contribution
  • 2 Foreword/postscript
  • 1 Book

Research output per year

Research output per year

Search results

• 2024

  Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms

  Baranwal, A., Basmaci, R., He, R., Viswanatha, D., Greipp, P., Murthy, H. S., Foran, J., Palmer, J., Hogan, W., Litzow, M. R., Hefazi, M., Mangaonkar, A., Shah, M. V., Al-Kali, A. & Alkhateeb, H. B., Feb 13 2024, In: Blood Advances. 8, 3, p. 562-570 9 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia

  Gangat, N., McCullough, K., Abdelmagid, M., Karrar, O., Powell, M., Al-Kali, A., Alkhateeb, H., Begna, K., Mangaonkar, A., Saliba, A., Torghabeh, M. H., Litzow, M., Hogan, W., Shah, M., Patnaik, M., Pardanani, A., Badar, T., Foran, J., Palmer, J., Sproat, L., & 2 othersYi, C. A. & Tefferi, A., Jan 2024, In: Haematologica. 109, 1, p. 287-292 6 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up

  Abdallah, N., Witzig, T. E., Kumar, S. K., Lacy, M. Q., Hayman, S. R., Dispenzieri, A., Roy, V., Gertz, M. A., Bergsagel, P. L. & Rajkumar, S. V., 2024, (Accepted/In press) In: Leukemia.

  Research output: Contribution to journal › Letter › peer-review

• Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival

  Karrar, O., Abdelmagid, M., Rana, M., Iftikhar, M., McCullough, K., Al-Kali, A., Alkhateeb, H. B., Begna, K. H., Elliott, M. A., Mangaonkar, A., Saliba, A., Hefazi Torghabeh, M., Litzow, M. R., Hogan, W., Shah, M., Patnaik, M. M., Pardanani, A., Badar, T., Murthy, H., Foran, J., & 6 othersPalmer, J., Sproat, L., Khera, N., Arana Yi, C., Tefferi, A. & Gangat, N., Feb 2024, In: American journal of hematology. 99, 2, p. E63-E66

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2023

  Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  Abdallah, M., McCullough, K., Ilyas, R., Begna, K. H., Al-Kali, A., Litzow, M. R., Hogan, W. J., Mangaonkar, A., Alkhateeb, H., Shah, M. V., Elliott, M. A., Foran, J. M., Badar, T., Palmer, J. M., Yi, C. A., Sproat, L., Pardanani, A., Patnaik, M. M., Olteanu, H., Ketterling, R. P., & 2 othersTefferi, A. & Gangat, N., Dec 2023, In: Blood cancer journal. 13, 1, 35.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: The Mayo Clinic experience

  Katamesh, B., Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Greipp, P., Bessonen, K., Gangat, N., Begna, K., Mangaonkar, A., Patnaik, M., Hogan, W. J., Tefferi, A., Litzow, M., Shah, M. V., Yi, C. A., Foran, J., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Apr 25 2023, In: Blood Advances. 7, 8, p. 1351-1355 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms

  Katamesh, B., Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Greipp, P., Foran, J., Begna, K., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M., Mangaonkar, A., Shah, M. V., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Jan 2023, In: Annals of hematology. 102, 1, p. 211-212 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

  Moreau, P., Chari, A., Oriol, A., Martinez-Lopez, J., Haenel, M., Touzeau, C., Ailawadhi, S., Besemer, B., de la Rubia Comos, J., Encinas, C., Mateos, M. V., Salwender, H., Rodriguez-Otero, P., Hulin, C., Karlin, L., Sureda Balari, A., Bargay, J., Benboubker, L., Rosiñol, L., Tarantolo, S., & 8 othersTerebelo, H., Yang, S., Wang, J., Nnane, I., Qi, M., Kosh, M., Delioukina, M. & Goldschmidt, H., Dec 2023, In: Blood cancer journal. 13, 1, 33.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

  Dhakal, B., Zhang, M. J., Burns, L. J., Tang, X., Meyer, C., Mau, L. W., Nooka, A. K., Stadtmauer, E., Micallef, I. N., McGuirk, J., Costa, L., Juckett, M. B., Shah, N., Champlin, R. E., Usmani, S. Z., Farag, S. S., Nishihori, T., Roy, V., Bodiford, A., Barnes, Y. J., & 3 othersDrea, E. J., Hari, P. & Hamadani, M., Aug 2023, In: Haematologica. 108, 8, p. 2249-2254 6 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET

  Chohan, K. L., Young, J. R., Lester, S., Moustafa, M. A., Rosenthal, A., Tun, H. W., Hoppe, B. S., Johnston, P. B., Micallef, I. N., Habermann, T. M. & Ansell, S. M., Jun 2023, In: Haematologica. 108, 6, p. 1697-1701 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience

  Gangat, N., Ajufo, H., Abdelmagid, M., Karrar, O., McCullough, K., Badar, T., Foran, J., Palmer, J., Alkhateeb, H., Mangaonkar, A., Kuykendall, A., Rampal, R. K. & Tefferi, A., Nov 2023, In: British journal of haematology. 203, 3, p. e87-e92

  Research output: Contribution to journal › Letter › peer-review

• Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

  Al-Kali, A., Nanaa, A., Viswanatha, D., He, R., Nguyen, P., Jevremovic, D., Foran, J. M., Yi, C. A., Greipp, P. T., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M. R., Mangaonkar, A. A., Shah, M. V., Badar, T. & Alkhateeb, H. B., Dec 2023, In: Blood cancer journal. 13, 1, 49.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants

  Ferrer, A., Lasho, T., Fernandez, J. A., Steinauer, N. P., Simon, R. A., Finke, C. M., Carmona, E. M., Wylam, M. E., Ongie, L. J., Burnap, B. N., Arana Yi, C., Sproat, L. Z., Foran, J., Badar, T., Mangaonkar, A. A. & Patnaik, M. M., Dec 2023, In: American journal of hematology. 98, 12, p. E357-E359

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates

  Saliba, A. N., Kaufmann, S. H., Stein, E. M., Patel, P. A., Baer, M. R., Stock, W., Deininger, M., Blum, W., Schiller, G. J., Olin, R. L., Litzow, M. R., Lin, T. L., Ball, B. J., Boyiadzis, M. M., Traer, E., Odenike, O., Arellano, M. L., Walker, A., Duong, V. H., Kovacsovics, T., & 20 othersCollins, R. H., Shoben, A. B., Heerema, N. A., Foster, M. C., Peterson, K. L., Schneider, P. A., Martycz, M., Gana, T. J., Rosenberg, L., Marcus, S., Yocum, A. O., Chen, T., Stefanos, M., Mims, A. S., Borate, U., Burd, A., Druker, B. J., Levine, R. L., Byrd, J. C. & Foran, J. M., Jun 13 2023, In: Blood Advances. 7, 11, p. 2360-2363 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm

  Gangat, N., Ilyas, R., McCullough, K., Begna, K. H., Al-Kali, A., Patnaik, M. M., Litzow, M. R., Hogan, W. J., Mangaonkar, A., Alkhateeb, H., Shah, M. V., Elliott, M. A., Foran, J. M., Badar, T., Palmer, J. M., Hanson, C. A., Pardanani, A. & Tefferi, A., May 2023, In: Haematologica. 108, 5, p. 1423-1428 6 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases

  Fleti, F., Chan, O., Singh, A., Abdelmagid, M. G., Al-Kali, A., Elliott, M. A., Begna, K. H., Foran, J. M., Badar, T., Khera, N., Al Ali, N. H., Padron, E., Sallman, D. A., Shah, M., Hiwase, D., Pardanani, A., Arber, D. A., Orazi, A., Reichard, K. K., He, R., & 4 othersKetterling, R. P., Gangat, N., Komrokji, R. & Tefferi, A., Apr 2023, In: American journal of hematology. 98, 4, p. E76-E79

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2022

  A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome

  Komrokji, R. S., Carraway, H. E., Germing, U., Wermke, M., Zeidan, A. M., Fu, E., Rüter, B., Burkard, U., Osswald, A. & Foran, J. M., Nov 2022, In: Haematologica. 107, 11, p. 2742-2747 6 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Autoimmune manifestations in STAG2-mutated myeloid neoplasms

  Katamesh, B., Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Greipp, P., Foran, J., Begna, K., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M., Mangaonkar, A., Shah, M. V., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Dec 2022, In: Annals of hematology. 101, 12, p. 2785-2787 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases

  Abdelmagid, M. G., Litzow, M. R., McCullough, K. B., Gangat, N., Pardanani, A., Murthy, H. S., Foran, J. M., Ketterling, R. P., Viswanatha, D., Begna, K. H. & Tefferi, A., Jul 2022, In: Blood cancer journal. 12, 7, 103.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Comparison between GATA2 and DDX41-mutated myeloid neoplasms

  Nanaa, A., He, R., Viswanatha, D., Nguyen, P., Jevremovic, D., Foran, J. M., Yi, C. A., Greipp, P. T., Gangat, N., Patnaik, M., Tefferi, A., Litzow, M. R., Mangaonkar, A. A., Shah, M. V., Badar, T., Alkhateeb, H. B. & Al-Kali, A., Oct 2022, In: Leukemia Research. 121, 106931.

  Research output: Contribution to journal › Letter › peer-review

• Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms

  Gagnon, M. F., Tian, S., Geyer, S., Sharma, N., Vachon, C. M., Kusne, Y., Bergsagel, P. L., Stewart, A. K., Rajkumar, S. V., Kumar, S., Ailawadhi, S. & Baughn, L. B., Jul 2022, In: Blood cancer journal. 12, 7, 112.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy

  Longcor, J., Callander, N., Oliver, K., Chanan-Khan, A. & Ailawadhi, S., Sep 2022, In: Blood cancer journal. 12, 9, 130.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting

  Singh, A., Al-Kali, A., Foran, J. M., Elliott, M. A., Begna, K., Badar, T., Khera, N., Fleti, F., Abdelmagid, M., Reichard, K. K., Ketterling, R. P., Pardanani, A., Gangat, N. & Tefferi, A., Oct 2022, In: American journal of hematology. 97, 10, p. E377-E379

  Research output: Contribution to journal › Letter › peer-review

• Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience

  Gangat, N., McCullough, K., Al-Kali, A., Begna, K. H., Patnaik, M. M., Litzow, M. R., Hogan, W., Shah, M., Alkhateeb, H., Mangaonkar, A., Foran, J. M., Palmer, J. M., Pardanani, A. & Tefferi, A., Aug 2022, In: British journal of haematology. 198, 4, p. e54-e58

  Research output: Contribution to journal › Letter › peer-review

• Limited activity of luspatercept in myelofibrosis and myeloid neoplasms other than myelodysplastic syndromes with ring sideroblasts

  Gangat, N., Chetram, D., McCullough, K., Al-Kali, A., Begna, K., Hogan, W., Litzow, M., Foran, J., Badar, T., Palmer, J., Patnaik, M., Pardanani, A. & Tefferi, A., Dec 2022, In: American journal of hematology. 97, 12, p. E474-E477

  Research output: Contribution to journal › Letter › peer-review

• Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemia

  Baranwal, A., Nanaa, A., Viswanatha, D., He, R., Foran, J., Badar, T., Hogan, W. J., Litzow, M. R., Shah, M. V., Patnaik, M. M., Al-Kali, A. & Alkhateeb, H. B., Nov 2022, In: Bone Marrow Transplantation. 57, 11, p. 1716-1718 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival

  Badar, T., Atallah, E., Shallis, R. M., Goldberg, A. D., Patel, A., Abaza, Y., Bewersdorf, J. P., Saliba, A. N., Correia, G. S. D. C., Murthy, G., Duvall, A., Burkart, M., Stahl, M., Liu, Y., Dinner, S., Palmisiano, N., Litzow, M. R. & Foran, J. M., Jul 2022, In: American journal of hematology. 97, 7, p. E232-E235

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Plamotamab (XmAb^®13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenström macroglobulinemia

  Parrondo, R. D., Paulus, A., Alegria, V., Liebowitz, D., Johnson, C., Clynes, R., Roy, V., Menke, D. M., Jiang, L., Chanan-Khan, A. A. & Ailawadhi, S., 2022, In: Leukemia and Lymphoma. 63, 3, p. 738-742 5 p.

  Research output: Contribution to journal › Letter › peer-review

• Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts

  Farrukh, F., Chetram, D., Al-Kali, A., Foran, J., Patnaik, M., Badar, T., Begna, K., Hook, C., Hogan, W., McCullough, K. B., Mangaonkar, A., He, R., Gangat, N. & Tefferi, A., Jun 1 2022, In: American journal of hematology. 97, 6, p. E210-E214

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Real-world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts

  Gangat, N., McCullough, K., Johnson, I., Al-Kali, A., Begna, K. H., Patnaik, M. M., Litzow, M. R., Hogan, W., Shah, M., Alkhateeb, H., Mangaonkar, A., Foran, J. M., Badar, T., Palmer, J. M., Sproat, L., Arana Yi, C. Y., Pardanani, A. & Tefferi, A., Jun 1 2022, In: American journal of hematology. 97, 6, p. E214-E216

  Research output: Contribution to journal › Letter › peer-review

• Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance

  Ho, M., Zanwar, S., Buadi, F. K., Ailawadhi, S., Larsen, J., Bergsagel, L., Binder, M., Chanan-Khan, A., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Gonsalves, W., Go, R. S., Hayman, S., Kapoor, P., Kourelis, T., Lacy, M. Q., Leung, N., Lin, Y., & 10 othersMuchtar, E., Roy, V., Sher, T., Warsame, R., Fonder, A., Hobbs, M., Hwa, Y. L., Kyle, R. A., Rajkumar, S. V. & Kumar, S., Nov 3 2022, In: Blood. 140, 18, p. 1997-2000 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy

  Zanwar, S., Ho, M., Buadi, F. K., Ailawadhi, S., Larsen, J., Bergsagel, L., Binder, M., Chanan-Khan, A., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Gonsalves, W., Go, R. S., Hayman, S., Kapoor, P., Kourelis, T., Lacy, M. Q., Leung, N., Lin, Y., & 10 othersMuchtar, E., Roy, V., Sher, T., Warsame, R., Fonder, A., Hobbs, M., Hwa, Y. L., Kyle, R. A., Vincent Rajkumar, S. & Kumar, S., Nov 2022, In: Blood cancer journal. 12, 11, 160.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis

  Parrondo, R. D., Sam, K., Rasheed, A., Alegria, V., Sher, T., Roy, V., Chanan-Khan, A. & Ailawadhi, S., Apr 2022, In: Blood cancer journal. 12, 4, 66.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma

  Parrondo, R. D., Rahman, Z. A., Heckman, M. G., Wieczorek, M., Jiang, L., Alkhateeb, H. B., Litzow, M. R., Greipp, P., Sher, T., Bergsagel, L., Fonseca, R., Roy, V., Dispenzieri, A., Kharfan-Dabaja, M. A., Murthy, H. S., Ailawadhi, S. & Foran, J. M., Jun 2022, In: Blood cancer journal. 12, 6, 87.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm

  Gangat, N., Konopleva, M., Patnaik, M. M., Jabbour, E., DiNardo, C., Al-Kali, A., Foran, J. M., Granroth, G. L., Olteanu, H., Kadia, T., Tefferi, A. & Pemmaraju, N., Feb 1 2022, In: American journal of hematology. 97, 2, p. E62-E67

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2021

  A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma

  Ramasamy, K., Nooka, A., Quach, H., Htut, M., Popat, R., Liedtke, M., Tuchman, S. A., Laubach, J., Gasparetto, C., Chanan-Khan, A., Hertzberg, M., deMario, M., Nueesch, E., Chesne, E., Franjkovic, I., Lechner, K., Kornacker, M. & Cho, H. J., Sep 2021, In: Blood cancer journal. 11, 9, 149.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes

  Abdel-Rahman, Z. H., Heckman, M. G., Anagnostou, T., White, L. J., Kloft‐Nelson, S. M., Knudson, R. A., Alkhateeb, H. B., Sproat, L. Z., Khera, N., Murthy, H. S., Ayala, E., Hogan, W. J., Roy, V., Peterson, J. F., Kharfan-Dabaja, M. A., Ketterling, R. P., Litzow, M. R., Baughn, L. B., Patnaik, M., Greipp, P. T., & 1 othersForan, J. M., Sep 2021, In: Blood cancer journal. 11, 9, 156.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy

  Saliba, A. N., Xie, Z., Higgins, A. S., Andrade-Gonzalez, X. A., Fuentes-Bayne, H. E., Hampel, P. J., Kankeu Fonkoua, L. A., Childs, D. S., Rakshit, S., Bezerra, E. D., Kommalapati, A., Lou, Y., Rivera, C. E., Price, K. A., Chintakuntlawar, A., Yan, Y., Schwecke, A. J., Block, M. S., Thanarajasingam, U., Thanarajasingam, G., & 5 othersWolanskyj-Spinner, A. P., Marshall, A. L., Kottschade, L. A., Go, R. S. & Al-Kali, A., Oct 1 2021, In: American journal of hematology. 96, 10, p. E362-E367

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Incidence of Axillary Adenopathy in Breast Imaging after COVID-19 Vaccination

  Robinson, K. A., Maimone, S., Gococo-Benore, D. A., Li, Z., Advani, P. P. & Chumsri, S., Sep 2021, In: JAMA Oncology. 7, 9, p. 1395-1397 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Ixazomib and lenalidomide maintenance therapy in multiple myeloma

  Parrondo, R. D., Alegria, V., Roy, V., Sher, T., Chanan-Khan, A. A. & Ailawadhi, S., Mar 2021, In: Annals of hematology. 100, 3, p. 851-853 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia

  Saliba, A. N., Litzow, M. R., Gangat, N., Al-Kali, A., Foran, J. M., Hogan, W. J., Palmer, J. M., Mangaonkar, A. A., Tefferi, A. & Patnaik, M. M., Nov 1 2021, In: American journal of hematology. 96, 11, p. E433-E436

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation

  Joshi, M., Cook, J., McCullough, K., Nanaa, A., Gangat, N., Foran, J. M., Murthy, H. S., Kharfan-Dabaja, M. A., Sproat, L., Palmer, J., Pardanani, A., Tefferi, A., Begna, K., Elliot, M., Al-Kali, A., Patnaik, M., Shah, M. V., Hogan, W. J., Litzow, M. R. & Alkhateeb, H. B., Mar 2021, In: Blood cancer journal. 11, 3, 49.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect^® MM Registry

  Connect® MM Registry, Jul 2021, In: Blood cancer journal. 11, 7, 134.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
• 2020

  Association between High-grade Myelodysplastic Syndrome and Cutaneous Langerhans Cell Histiocytosis Suggested by Next-Generation Sequencing

  Khurana, S., Sluzevich, J. C., He, R., Reimer, D. K., Kharfan-Dabaja, M. A., Foran, J. M. & Jiang, L., Jul 2020, In: JAMA Dermatology. 156, 7, p. 817-819 3 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Clinical utility of fluorescence in situ hybridization-based diagnosis of BCR-ABL1 like (Philadelphia chromosome like) B-acute lymphoblastic leukemia

  Anagnostou, T., Knudson, R. A., Pearce, K. E., Meyer, R. G., Pitel, B. A., Peterson, J. F., Baughn, L. B., Reichard, K. K., Ketterling, R. P., Kloft-Nelson, S. M., Knutson, D. L., Khan, S. P., Gangat, N., Litzow, M. R., Hogan, W. J., Wolanskyj, A., Al-Kali, A., Begna, K. H., Elliott, M., Pardanani, A., & 8 othersForan, J., Shah, M., Tefferi, A., Alkhateeb, H., Halling, K., Rodriguez, V., Greipp, P. T. & Patnaik, M. M., Mar 1 2020, In: American journal of hematology. 95, 3, p. E68-E72

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations

• In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

  Marin-Acevedo, J. A., Chirila, R. M. & Dronca, R., Mar 2020, In: Mayo Clinic proceedings. 95, 3, p. 615 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas

  Rodriguez-Matta, E., Hemmerich, A., Starr, J., Mody, K., Severson, E. A. & Colon-Otero, G., 2020, In: Acta Oncologica. p. 1024-1027 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Reply to T.J.A. Dekker

  Modi, S., Park, H., Murthy, R. K., Iwata, H., Tamura, K., Tsurutani, J., Moreno-Aspitia, A., Doi, T., Sagara, Y., Redfern, C., Krop, I. E., Lee, C., Fujisaki, Y., Sugihara, M., Zhang, L., Shahidi, J. & Takahashi, S., Oct 1 2020, In: Journal of Clinical Oncology. 38, 28, p. 3351-3352 2 p.

  Research output: Contribution to journal › Letter › peer-review
• 2019

  Drug-associated vasculitis occurring after treatment with pembrolizumab

  Tolaymat, O. A., Pinkston, O., Wang, B., Schenk, W. B., Joseph, R. W., Mergo, P. J. & Berianu, F., Aug 1 2019, In: Rheumatology (United Kingdom). 58, 8, p. 1501-1503 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

  Kharfan-Dabaja, M. A., Jain, M. D., Aulakh, S., Ayala, E., Zubair, A. C., Tun, H. W., Liu, H. D., Locke, F. L. & Chavez, J. C., Sep 2019, In: American journal of hematology. 94, 9, p. E245-E247

  Research output: Contribution to journal › Letter › peer-review

  Open Access